Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank JTrust Indonesia Tbk (BCIC) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank JTrust Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank JTrust Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank JTrust Indonesia Tbk trades at Rp117 (market cap 2.08T, 789K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank JTrust Indonesia Tbk is far larger — about 12.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank JTrust Indonesia Tbk is more actively traded (789K versus 214.9K). Which is the better fit depends on your goals.

BCICOBAT
Market Cap
2.08T164.65B
Volume
789K214.9K
Lot
7.89K2.15K
Turnover
91.89M51.97M
Average Price
116.46241.85
Value
91.89M51.97M
Indicative Equilibrium Price
117240
Indicative Equilibrium Volume
535100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCIC
View details
OBAT
View details

About Bank JTrust Indonesia Tbk

PT Bank JTrust Indonesia Tbk (formerly PT Bank Mutiara Tbk) (“Bank”) was established under the name of PT Bank Century Intervest Corporation by deed No. 136 dated May 30, 1989 of Lina Laksmiwardhani, SH, substituteof Lukman Kirana, SH, Notary in Jakarta. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia in its Decision Letter No. C2-6196.HT.01.01.TH’89 dated July 12, 1989 and published in the State Gazette of the Republic of Indonesia No. 36 Supplement No. 1959 dated May 4, 1993. Then the Bankconducted a business consolidation through merger with other banks in 2004.

Read more on BCIC

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT